QUOTED. March 9, 2018. David Northfield.
Executive Summary
Check out what London-based attorney David Northfield had to say about how device companies should approach disputes with notified bodies in the EU.
You may also be interested in...
What Should Companies Do When Their Notified Body Relationship Sours?
The vast majority of medical device and IVD manufacturers are dependent on their notified bodies to grant them certificates of conformity to the EU's medtech rules. But what happens when they don't see eye-to-eye?
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.